why and how we can use caflam

ANTI-INFLAMMATORY AND ANTI-RHEUMATIC PRODUCT, NON-STEROID, ACETIC ACID DERIVATIVE.

DESCRIPTION AND COMPOSITION:-

SUGAR-COATED TABLETS.

ACTIVE MOIETY:

DICLOFENAC

INDICATIONS:

MIGRAINE ATTACKS.
NON-ARTICULAR RHEUMATISM.
PAINFUL SYNDROMES OF THE VERTEBRAL COLUMN.
POST-TRAUMATIC PAIN, INFLAMMATION, AND SWELLING, E. G DUE TO SPRAINS.
POST-OPERATIVE PAIN INFLAMMATION AND SWELLING, E. G FOLLOWING DENTAL OR ORTHOPEDIC SURGERY.

DOSAGE AND ADMINISTRATION :

DOSAGE:

AS A GENERAL RECOMMENDATION, THE DOSE SHOULD BE INDIVIDUALLY ADJUSTED. ADVERSE EFFECTS MAY BE MINIMIZED BY USING THE LOWEST EFFECTIVE DOSE FOR THE SHORTEST DURATION NECESSARY TO CONTROL SYMPTOMS.

GENERAL TARGET POPULATION :

ADULTS:

THE RECOMMENDED INITIAL DAILY DOSE IS 100 TO 150MG.IN MILDER CASES, 75 TO 100MG DAILY IS USUALLY SUFFICIENT.

THE TOTAL DAILY DOSE SHOULD GENERALLY BE DIVIDED INTO 2 OR 3 SEPARATE DOSES, AS APPLICABLE.

IN PRIMARY AMENORRHEA, THE DAILY DOSE SHOULD BE INDIVIDUALLY ADJUSTED AND IS GENERALLY 50 TO 150MG. AN INITIAL DOSE OF 50MG IS USUALLY SUFFICIENT. IF NECESSARY AN INITIAL DOSE OF 100MG CAN BE PRESCRIBED WITH A MAXIMUM OF 200MG/DAY REACHED THROUGHOUT SEVERAL MENSTRUAL CYCLES. TREATMENT SHOULD BE STARTED ON THE APPEARANCE OF THE FIRST SYMPTOMS AND, DEPENDING ON THE SYMPTOMATOLOGY, CONTINUED FOR A FEW DAYS. IN CASE WHERE PAIN RELIEF WITHIN TWO HOURS AFTER THE FIRST DOSE IS NOT SUFFICIENT, A FURTHER DOSE OF 50MG MAY BE TAKEN. IF NEEDED, A FURTHER DOSE OF 50MG MAY BE TAKEN AT INTERVALS OF 4 TO 6 HOURS, NOT EXCEEDING A TOTAL DOSE OF 200MG PER DAY.

GERIATRIC PATIENTS (AGED 65 YEARS OR ABOVE):

NO ADJUSTMENT OF STARTING DOSE IS GENERALLY REQUIRED FOR ELDERLY PATIENTS HOWEVER, CAUTION IS INDICATED ON BASIC MEDICAL GROUNDS, ESPECIALLY FOR FRAIL ELDERLY PATIENTS OR THOSE WITH A LOW BODY WEIGHT.

PEDIATRIC PATIENTS (BELOW 18 YEARS OF AGE):-

TABLETS ARE NOT RECOMMENDED FOR USE IN CHILDREN AND ADOLESCENTS BELOW 14 YEARS OF AGE, FOR TREATMENT IN CHILDREN BELOW 14 YEARS OF AGE, ORAL DROPS OR SUPPOSITORIES OF DICLOFENAC 12.5 MG AND 25MG COULD BE USED. FOR ADOLESCENTS AGED 14 YEARS AND OVER, A DAILY DOSE OF 75MG TO 100MG IS USUALLY SUFFICIENT.

METHOD OF ADMINISTRATION:-

THE TABLETS SHOULD BE SWALLOWED WHOLE WITH LIQUID, PREFERABLY BEFORE MEALS, AND MUST NOT BE DIVIDED OR CHEWED.

PREGNANCY:-

THERE ARE INSUFFICIENT DATA ON THE USE OF DICLOFENAC IN PREGNANT WOMEN. IT SHOULD NOT BE USED DURING THE FIRST TWO TRIMESTERS OF PREGNANCY UNLESS THE EXPECTED BENEFITS TO THE MOTHER OUTWEIGH THE RISKS TO THE FETUS.

BREASTFEEDING:

LIKE OTHER NSAIDs, DICLOFENAC PASSES INTO THE BREAST MILK IN SMALL AMOUNT. THEREFORE, IT SHOULD NOT BE ADMINISTERED DURING BREASTFEEDING TO AVOID UNDESIRABLE EFFECTS ON THE INFANT.

FERTILITY:

AS WITH OTHER NSAIDs, THE USE OF THE TABLET MAY BE TO IMPAIR FEMALE FERTILITY AND IS NOT RECOMMENDED IN WOMEN ATTEMPTING TO CONCEIVE.

OVERDOSE:-

THERE IS NO TYPICAL CLINICAL PICTURE RESULTING FROM DICLOFENAC OVERDOSE.

OVERDOSE CAN CAUSE SYMPTOMS SUCH AS VOMITING, GASTROINTESTINAL HEMORRHAGE, DIARRHEA, DIZZINESS, TINNITUS, OR CONVULSIONS. IN THE EVENT OF SIGNIFICANT POISONING, ACUTE RENAL FAILURE AND LIVER DAMAGE ARE POSSIBLE.

CLINICAL STUDIES:-

IT IS A WELL-ESTABLISHED PRODUCT.

STORAGE:

PLEASE SEE THE FOLDING BOX TO STORE IT